Hepatitis Monthly

Published by: Kowsar

Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population

Khalid A. Alswat 1 , * , Faisal M. Sanai 2 , Mansour Altuwaijri 1 , Ali Albenmousa 3 , Majid Almadi 1 , Waleed K. Al-Hamoudi 1 and Ayman A. Abdo 1
Authors Information
1 Department of Medicine, Liver Disease Research Center, King Saud University, Riyadh, Saudi Arabia
2 Department of Hepatobiliary Science and Liver Transplantation, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia
3 Department of Gastroenterology, Riyadh Military Hospital, Riyadh, Saudi Arabia
Article information
  • Hepatitis Monthly: May 01, 2013, 13 (5); e7612
  • Published Online: May 8, 2013
  • Article Type: Research Article
  • Received: August 7, 2012
  • Revised: December 2, 2012
  • Accepted: January 19, 2013
  • DOI: 10.5812/hepatmon.7612

To Cite: Alswat K A, Sanai F M, Altuwaijri M, Albenmousa A, Almadi M, et al. Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population, Hepat Mon. 2013 ; 13(5):e7612. doi: 10.5812/hepatmon.7612.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. The GLOBOCAN project. 2008;
  • 2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004; 127(5 Suppl 1)
  • 3. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127(5 Suppl 1)
  • 4. Saudi Cancer Registry Report. 2005;
  • 5. Abdo AA, Al Abdul Karim H, Al Fuhaid T, Sanai FM, Kabbani M, Al Jumah AR, et al. Saudi gastroenterology association guidelines for the diagnosis and management of hepatocellular carcinoma: summary of recommendations. Saudi J Gastroenterol. 2007; 13(1): 45-8[DOI][PubMed]
  • 6. Al-Faleh FZ. Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades. Ann Saudi Med. 2003; 23(6): 367-71[PubMed]
  • 7. Al-Faleh FZ, Al-Jeffri MH, Al-Rashed RS, Aref M. Efficacy of hepatitis B vaccine in a cohortcommunity-based study in Riyadh and Hail regions of Saudi Arabia. Saudi J Gastroenterol. 2002; 8(3): 81-4[PubMed]
  • 8. al-Faleh FZ, Ayoola EA, Arif M, Ramia S, al-Rashed R, al-Jeffry M, et al. Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. J Infect. 1992; 24(2): 197-206[PubMed]
  • 9. Arya SC, Ashraf SJ, Parande CM, el-Sayed M, Sahay R, Ageel AR, et al. Hepatitis B virus in Gizan, Saudi Arabia. J Med Virol. 1985; 17(3): 267-74[PubMed]
  • 10. Parande CM, Arya SC, Ashraf SJ. Hepatitis B virus among Saudi children in Gizan, Saudi Arabia. Infection. 1986; 14(5): 223-5[PubMed]
  • 11. Shobokshi OA, Serebour FE. The aetiology of acute viral hepatitis in the western region of Saudi Arabia. Trans R Soc Trop Med Hyg. 1987; 81(2): 219-21[PubMed]
  • 12. Al-Faleh FZ, Ayoola EA, Al-Jeffry M, Arif M, Al-Rashed RS, Ramia S. Integration of hepatitis B vaccine into the expanded program on immunization: The Saudi Arabian experience. Ann Saudi Med. 1993; 13(3): 231-6[PubMed]
  • 13. al-Faleh FZ, Ayoola EA, al-Jeffry M, al-Rashed R, al-Mofarreh M, Arif M, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology. 1991; 14(2): 215-8[PubMed]
  • 14. Shobokshi OA, Serebour FE, Al-Drees AZ, Mitwalli AH, Qahtani A, Skakni LI. Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J. 2003; 24 Suppl 2-6[PubMed]
  • 15. Memish ZA, Knawy BA, El-Saed A. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis. 2010; 14(2)-20[DOI][PubMed]
  • 16. Buch SC, Kondragunta V, Branch RA, Carr BI. Gender-based outcomes differences in unresectable hepatocellular carcinoma. Hepatol Int. 2008; 2(1): 95-101[DOI][PubMed]
  • 17. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005; 42(5): 1208-36[DOI][PubMed]
  • 18. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology. 2000; 31(4): 840-5[DOI][PubMed]
  • 19. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003; 38(1): 258-66[DOI][PubMed]
  • 20. Mullen KD. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther. 2007; 25 Suppl 1: 11-6[DOI][PubMed]
  • 21. Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999; 94(11): 3285-91[DOI][PubMed]
  • 22. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981; 2(8256): 1129-33[PubMed]
  • 23. Prates MD, Torres FO. A cancer survey in Lourenco Marques, Portuguese East Africa. J Natl Cancer Inst. 1965; 35(5): 729-57[PubMed]
  • 24. Fashir B, Sivasubramaniam V, Al-Momen S, Assaf H. Hepatic tumors in a Saudi patients population. Saudi J Gastroenterol. 1996; 2(2): 87-90[PubMed]
  • 25. Kingston M, Ali MA, Lewall D. Hepatic tumors in Saudi Arabia. A practical approach to diagnosis. Cancer. 1985; 55(7): 1579-85[PubMed]
  • 26. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007; 317(5834): 121-4[DOI][PubMed]
  • 27. Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res. 1993; 53(4): 790-4[PubMed]
  • 28. Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnu L, et al. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 2009; 21(10): 1212-8[DOI][PubMed]
  • 29. Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN, et al. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol. 2011; 29(27): 3643-50[DOI][PubMed]
  • 30. Tangkijvanich P, Mahachai V, Suwangool P, Poovorawan Y. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol. 2004; 10(11): 1547-50[PubMed]
  • 31. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet. 1999; 353(9160): 1253-7[DOI]
  • 32. Bruix J, Calvet X, Costa J, Ventura M, Bruguera M, Castillo R, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. The Lancet. 1989; 334(8670): 1004-6
  • 33. Butt AS, Abbas Z, Jafri W. Hepatocellular carcinoma in pakistan: where do we stand? Hepat Mon. 2012; 12(10 HCC)[DOI][PubMed]
  • 34. Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chappell CL, et al. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol. 2001; 33(2): 123-6[PubMed]
  • 35. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993; 328(25): 1797-801[DOI][PubMed]
  • 36. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132(7): 2557-76[DOI][PubMed]
  • 37. Fakunle YM, Al-Mofarreh M, El-Drees AZ, El-Karamany WM, Ezzat HO, Ballesteros MN, et al. Prevalence of antibodies to hepatitis C virus in Saudi patients with chronic liver disease. Ann Saudi Med. 1991; 11(5): 497-500[PubMed]
  • 38. Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. J Gastroenterol Hepatol. 2004; 19(6): 665-9[DOI][PubMed]
  • 39. Saeed AA, Ahmed AM, Al-Karawi MA, Mohamed AR, Al-Saud AA, Shariq SA. The association between hepatitis C virus antibody and hepatocellular carcinoma in relation to hepatitis B viral infection (RAFH experinece). Ann Saudi Med. 1992; 12(3): 283-5[PubMed]
  • 40. Alfaleh F, Alshehri S, Alansari S, Aljeffri M, Almazrou Y, Shaffi A, et al. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect. 2008; 57(5): 404-9[DOI][PubMed]
  • 41. el-Zayadi AR, Badran HM, Barakat EM, Attia Mel D, Shawky S, Mohamed MK, et al. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol. 2005; 11(33): 5193-8[PubMed]
  • 42. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008; 26(49): 6266-73[DOI][PubMed]
  • 43. Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol. 1999; 31(1): 133-41
  • 44. Henderson JM, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T. AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford). 2003; 5(4): 243-50[DOI][PubMed]
  • 45. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19(3): 329-38[DOI][PubMed]
  • 46. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53(3): 1020-2[DOI][PubMed]
  • 47. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56(4): 908-43[DOI][PubMed]
  • 48. McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology. 2000; 32(4 Pt 1): 842-6[DOI][PubMed]
  • 49. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 2004; 126(4): 1005-14[PubMed]
  • 50. Wun YT, Dickinson JA. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. Cochrane Database Syst Rev. 2003(2)[DOI][PubMed]
  • 51. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004; 130(7): 417-22[DOI][PubMed]
  • 52. Abdo AA, Hassanain M, AlJumah A, Al Olayan A, Sanai FM, Alsuhaibani HA, et al. Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines. Ann Saudi Med. 2012; 32(2): 174-99[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments